Jan 11, 2017

CEO Note - Clinical Study Update and a Review of 2016 Accomplishments

Dec 21, 2016

Passage of the 21st Century Cures Act and its Potential Implications on Biodefense

Dec 15, 2016

Aethlon Announces Initiation of Sepsis-Related Virus Study

Nov 10, 2016

Aethlon Medical Announces Fiscal 2017 Second Quarter Results

Nov 3, 2016

Aethlon Medical To Host Second Quarter Fiscal 2017 Investor Call On November 10, 2016

Oct 13, 2016

Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation

Oct 12, 2016

Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum

Sep 20, 2016

Aethlon Medical Updates Corporate Presentation Schedule

Sep 12, 2016

Aethlon Medical To Present At The Rodman & Renshaw 18th Annual Global Investment Conference On September 13, 2016

Sep 9, 2016

The Dilemma in Funding Zika and Other Pandemic Therapies